ACS Heroes of Chemistry Award case study graphic celebrating scientific innovation and impact.

Project Overview

In 2025, the LUMAKRAS team was recognized as an American Chemical Society Heroes of Chemistry recipient, an honor celebrating the scientific innovation and persistence behind LUMAKRAS, Amgen's first-in-class KRAS G12C inhibitor.

The recognition created an opportunity to tell a broader story about the people and science behind a target once considered "undruggable." The goal was to celebrate the achievement while making the science more accessible and reinforcing Amgen's leadership in oncology and bold scientific innovation.

Strategy

To amplify the achievement, a targeted communications campaign was developed to showcase Amgen's leadership in oncology, engage internal and external audiences, and reinforce the company's reputation for bold science and meaningful impact.

The campaign connected science storytelling, executive visibility, employee engagement, social amplification, and earned media around a single innovation story. The work highlighted the breakthrough while keeping the human side of the discovery visible through scientist-centered storytelling and clear editorial framing.

Campaign Assets

Scientist spotlight portrait for ACS Heroes of Chemistry story.
Profile

Scientist Spotlight

Scientist-centered storytelling featuring an Amgen research leader and the people behind the ACS Heroes of Chemistry recognition.

Read More
Molecular visual for Cracking the KRAS Code article.
Article

Cracking the KRAS Code

Amgen.com feature content explaining the scientific journey behind LUMAKRAS and the persistence required to pursue a once-undruggable target.

Read More
Enterprise LinkedIn post preview for ACS Heroes of Chemistry recognition.
Social Media

Executive & Channel Activation

LinkedIn, X, ACS-produced social video, executive thought leadership posts, internal news, and Viva Engage amplification extended the story across audiences.

Results

Beyond the numbers, the campaign made a complex scientific breakthrough more accessible by putting the people behind the discovery at the center of the story. The integrated approach reinforced Amgen's leadership in oncology, elevated senior leader and scientist visibility, and demonstrated how a major scientific recognition can become a sustained, multi-channel storytelling opportunity.

ACS Heroes of Chemistry results graphic showing page views, engagements, earned media impressions, and social impressions.